ストックスクリーナーアプリを入手
3.72
4.06%
0.15
前日終値:
$3.57
開ける：
$3.66
24時間の取引高:
234.13K
Relative Volume:
0.20
時価総額：
$325.69M
収益：
$73.48M
当期純損益:
$-108.30M
株価収益率:
-1.6533
EPS:
-2.25
ネットキャッシュフロー:
$-67.17M
1週間 パフォーマンス:
-10.27%
1か月 パフォーマンス:
-32.58%
6か月 パフォーマンス:
-34.71%
1年 パフォーマンス:
+135.13%
1日の値動き範囲:
$3.62
$3.78
1週間の範囲:
$3.38
$4.0366
52週間の値動き範囲:
$1.135
$7.20
Personalis Inc Stock (PSNL) Company Profile
PSNL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
3.72 | 325.69M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
517.27 | 195.34B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
208.68 | 149.60B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
119.42 | 33.84B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
412.70 | 33.52B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
183.86 | 32.24B | 15.41B | 1.37B | 2.11B | 7.50 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-02-06 | アップグレード | Needham | Hold → Buy |
| 2022-01-07 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | ダウングレード | Needham | Buy → Hold |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-20 | 繰り返されました | Needham | Buy |
| 2021-05-06 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-12 | 繰り返されました | Needham | Buy |
| 2020-11-06 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-10-19 | 開始されました | Citigroup | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-08-27 | 開始されました | H.C. Wainwright | Buy |
| 2020-08-18 | 開始されました | Needham | Buy |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 開始されました | BofA/Merrill | Neutral |
| 2019-07-15 | 開始されました | Cowen | Outperform |
| 2019-07-15 | 開始されました | Morgan Stanley | Overweight |
| 2019-07-15 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Personalis Inc (PSNL) 最新ニュース
Hold Rating for Personalis: Balancing Strong Enterprise Sales and Future Uncertainties - TipRanks
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga
Personalis Stock Price, Quotes and Forecasts | NASDAQ:PSNL - Benzinga
Personalis stock target cut to $7 by BTIG, maintains Buy rating - Investing.com Canada
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Yahoo Finance
Personalis’ (PSNL) “Buy” Rating Reiterated at HC Wainwright - Defense World
Needham & Company LLC Cuts Personalis (NASDAQ:PSNL) Price Target to $7.00 - Defense World
Personalis, Inc. (NASDAQ:PSNL) Just Reported Earnings, And Analysts Cut Their Target Price - Simply Wall St
Personalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLC - MarketBeat
Personalis Full Year 2024 Earnings: Beats Expectations - Yahoo Finance UK
Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results - MarketBeat
Personalis stock target cut to $7.00 at Needham, retains buy rating By Investing.com - Investing.com South Africa
Personalis (NASDAQ:PSNL) Announces Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
Personalis files to sell 14.04M shares of common stock for holders - MSN
Personalis stock target cut to $7.00 at Needham, retains buy rating - Investing.com Canada
Personalis, Inc. (NASDAQ:PSNL) Q4 2024 Earnings Call Transcript - Insider Monkey
A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts - Benzinga
Personalis Inc (PSNL) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
ARK Investment Management LLC Sells 310,088 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Personalis Inc (PSNL) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Personalis: Q4 Earnings Snapshot - Thehour.com
Personalis’ Earnings Call: Growth Amid Challenges - TipRanks
Personalis Reports Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Personalis Reports 2024 Growth and Strategic Partnerships - TipRanks
Personalis (PSNL) Reports Q4 Loss, Tops Revenue Estimates - MSN
Earnings call transcript: Personalis Q4 2024 beats EPS forecast, stock dips - Investing.com India
Personalis: Q4 Earnings Snapshot -February 27, 2025 at 04:23 pm EST - Marketscreener.com
Personalis price target lowered to $8 from $11 at H.C. Wainwright - MSN
Personalis Inc to Host Earnings Call - ACCESS Newswire
Personalis Inc (PSNL) Q4 2024 Earnings Report Preview: What To L - GuruFocus.com
Personalis Inc (PSNL) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Personalis Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates - MSN
Personalis Inc (NASDAQ: PSNL) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
Personalis (PSNL) to Release Earnings on Thursday - MarketBeat
Personalis (PSNL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Personalis Inc (PSNL) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
Personalis (PSNL) Projected to Post Earnings on Wednesday - Defense World
Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference - Business Wire
PSNLPersonalis Latest Stock News & Market Updates - StockTitan
297,889 Shares in Personalis, Inc. (NASDAQ:PSNL) Bought by abrdn plc - MarketBeat
Exciting Technology At Personalis, But Profitability Eludes Them (NASDAQ:PSNL) - Seeking Alpha
SG Americas Securities LLC Buys New Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Sumitomo Mitsui Trust Group Inc. Sells 59,295 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Cancer Genomics Pioneer Personalis Unveils Q4 Earnings DateKey Details Inside - StockTitan
Understanding the Risks of Investing in Personalis Inc (PSNL) - Knox Daily
Wall Street analysts’ outlook for Personalis Inc (PSNL) - SETE News
Should You Expect A Quick Recovery From Personalis Inc (NASDAQ: PSNL) After -35.08% Decline From High? - Marketing Sentinel
BlackRock, Inc.'s Strategic Acquisition of Personalis Inc. Shares - GuruFocus.com
Personalis Inc (PSNL) is a good investment, but the stock may be overvalued - US Post News
Personalis Inc (PSNL) 財務データ
収益
当期純利益
現金流量
EPS
Personalis Inc (PSNL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
| Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
| Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Nov 18 '24 |
Sale |
3.79 |
1,693 |
6,416 |
67,388 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Nov 18 '24 |
Sale |
3.79 |
921 |
3,491 |
128,720 |
| Hall Christopher M | PRESIDENT AND CEO |
Nov 01 '24 |
Sale |
5.38 |
26,443 |
142,263 |
178,098 |
| Tempus AI, Inc. | 10% Owner |
Aug 16 '24 |
Buy |
5.07 |
3,500,000 |
17,745,000 |
12,718,800 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jul 30 '24 |
Sale |
2.97 |
524 |
1,556 |
127,227 |
1.53%
0.15%
大文字化:
|
ボリューム (24 時間):